ASH meeting

May 16, 2016May 16, 2016

Epizyme to Present Clinical Data on NHL Treatment at ASH Lymphoma Conference

News

Epizyme, Inc., recently announced it will present four abstracts at the upcoming American Society of Hematology (ASH) Conference on Lymphoma Biology. The abstracts report data from its clinical development program of tazemetostat in patients ... Read more

January 7, 2016January 7, 2016

2 Lymphoma Studies Using CAR T-cell Therapy Report ‘Tremendously Exciting’ Results

News

Presentations at the recent ASH annual meeting reporting novel results from small-scale clinical trials using CAR T-cell technology to treat lymphoma patients were reviewed in very enthusiastic terms by Dr. Marcela Maus, from the Massachusetts General Hospital Cancer Center, ... Read more

December 22, 2015December 22, 2015

Relapsed Mantle Cell Lymphoma Study Finds Ibrutinib Superior to Temsirolimus as Treatment

News

A Phase 3 study comparing two therapies in patients with previously treated mantle cell lymphoma has found the drug ibrutinib to be superior to temsirolimus in terms of progression-free survival and overall response rate. The trial’s ... Read more

December 7, 2015May 13, 2016

Leukemia and Lymphoma Society in 3 New Efforts to Treat, Cure Blood Cancers

News

The Leukemia & Lymphoma Society (LLS) recently announced three efforts, including two partnerships, to advance groundbreaking research and patient support, reinforcing its leadership in continuing efforts to find cures and new therapies for ... Read more